CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer

World Journal of Surgery

Volumn 33, Issue 4, 2009, Pages 710-715

  Donahue, Timothy R ^a   Hines, O Joe ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CHEMOKINE RECEPTOR CXCR2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; PROTEIN RET;

ANGIOGENESIS; CELL INVASION; GENETIC ASSOCIATION; HUMAN; NONHUMAN; PANCREAS CANCER; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; UPREGULATION;

GENE EXPRESSION PROFILING; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-RET; RECEPTORS, INTERLEUKIN-8B; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 62549149007     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-008-9826-z     Document Type: Review

References (50)

1. R Sachidanandam D Weissman SC Schmidt 2001 A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms Nature 409 928 933
2. ZE Sauna C Kimchi-Sarfaty SV Ambudkar MM Gottesman 2007 Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer Cancer Res 67 9609 9612
3. LM Dong JD Potter E White 2008 Genetic susceptibility to cancer: the role of polymorphisms in candidate genes JAMA 299 2423 2436
4. R Kuehn PI Lelkes C Bloechle 1999 Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatic diseases: angiogenesis in chronic pancreatitis and in pancreatic cancer Pancreas 18 96 103
5. S Karademir S Sokmen C Terzi 2000 Tumor angiogenesis as a prognostic predictor in pancreatic cancer J Hepatobiliary Pancreat Surg 7 489 495
6. S Fujioka K Yoshida S Yanagisawa 2001 Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival Cancer 92 1788 1797
7. P Buchler HA Reber MW Buchler 2002 VEGF-RII influences the prognosis of pancreatic cancer Ann Surg 236 738 749
8. HL Kindler G Friberg DA Singh 2005 Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer J Clin Oncol 23 8033 8040
9. M Sunamura DG Duda MH Ghattas 2003 Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer Angiogenesis 6 15 24
10. HU Kasper M Ebert P Malfertheiner 2001 Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density Virchows Arch 438 116 120
11. MN Wente MP Keane MD Burdick 2006 Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis Cancer Lett 241 221 227
12. RM Strieter 2005 Masters of angiogenesis Nat Med 11 925 927
13. G Semenza 2002 Signal transduction to hypoxia-inducible factor 1 Biochem Pharmacol 64 993 998
14. GL Semenza 2001 Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology Trends Mol Med 7 345 350
15. T Cramer Y Yamanishi BE Clausen 2003 HIF-1alpha is essential for myeloid cell-mediated inflammation Cell 112 645 657
16. G Bonizzi M Karin 2004 The two NF-kappaB activation pathways and their role in innate and adaptive immunity Trends Immunol 25 280 288
17. C Nakanishi M Toi 2005 Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs Nat Rev Cancer 5 297 309
18. A Richmond 2002 Nf-kappa B, chemokine gene transcription and tumour growth Nat Rev Immunol 2 664 674
19. M Baggiolini A Walz SL Kunkel 1998 Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils J Clin Invest 84 1045 1049
20. K Matsushima JJ Oppenheim 1998 Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF Cytokine 1 2 13
21. MD Miller MS Krangel 1992 Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines Crit Rev Immunol 12 17 46
22. JJ Oppenheim CO Zachariae N Mukaida K Matsushima 1991 Properties of the novel proinflammatory supergene "intercrine" cytokine family Annu Rev Immunol 9 617 648
23. JM Farber 1993 HuMig: a new human member of the chemokine family of cytokines Biochem Biophys Res Commun 192 223 230
24. P Proost C De Wolf-Peeters R Conings 1993 Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8 J Immunol 150 1000 1010
25. A Walz R Burgener B Car 1991 Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8 J Exp Med 174 1355 1362
26. RM Strieter PJ Polverini SL Kunkel 2001 The functional role of the ELR motif in CXC chemokine-mediated angiogenesis J Biol Chem 270 27348 27357
27. DA Arenberg SL Kunkel PJ Polverini 1996 Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice J Clin Invest 97 2792 2802
28. DA Arenberg MP Keane B DiGiovine 1998 Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer J Clin Invest 102 465 472
29. J Luan R Shattuck-Brandt H Haghnegahdar 1997 Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression J Leukoc Biol 62 588 597
30. DA Arenberg SL Kunkel PJ Polverini 1996 Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases J Exp Med 184 981 992
31. CL Addison DA Arenberg SB Morris 2000 The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis Hum Gene Ther 11 247 261
32. RM Strieter SL Kunkel DA Arenberg 1995 Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis Biochem Biophys Res Commun 210 51 57
33. CL Addison TO Daniel MD Burdick 2000 The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR + CXC chemokine-induced angiogenic activity J Immunol 165 5269 5277
34. PM Murphy 1994 The molecular biology of leukocyte chemoattractant receptors Annu Rev Immunol 12 593 633
35. X Le Q Shi B Wang 2000 Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma J Interferon Cytokine Res 20 935 946
36. Q Shi JL Abbruzzese S Huang 1999 Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic Clin Cancer Res 5 3711 3721
37. Q Shi X Le JL Abbruzzese 1999 Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia J Interferon Cytokine Res 19 1363 1371
38. M Gupta P Song CR Yates B Meibohm 2004 Real-time PCR-based genotyping assay for CXCR2 polymorphisms Clin Chim Acta 341 93 100
39. HP Yang K Woodson PR Taylor 2006 Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial Eur J Cancer Prev 15 249 253
40. E Renzoni P Lympany P Sestini 2000 Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis Arthritis Rheum 43 1633 1640
41. AC Viana YJ Kim JA Cirelli 2007 A novel PCR-RFLP assay for the detection of the single nucleotide polymorphism at position +1440 in the human CXCR2 gene Biochem Genet 45 737 741
42. LF Lin DH Doherty JD Lile 1993 GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1130 1132
43. MS Airaksinen M Saarma 2002 The GDNF family: signalling, biological functions and therapeutic value Nat Rev Neurosci 3 383 394
44. K Ketterer S Rao H Friess 2003 Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer Clin Cancer Res 9 5127 5136
45. Y Sakamoto Y Kitajima G Edakuni 2001 Expression of Trk tyrosine kinase receptor is a biologic marker for cell proliferation and perineural invasion of human pancreatic ductal adenocarcinoma Oncol Rep 8 477 484
46. H Sawai Y Okada K Kazanjian 2005 The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling Cancer Res 65 11536 11544
47. Y Ito Y Okada M Sato 2005 Expression of glial cell line-derived neurotrophic factor family members and their receptors in pancreatic cancers Surgery 138 788 794
48. Y Kodama N Asai K Kawai 2005 The RET proto-oncogene: a molecular therapeutic target in thyroid cancer Cancer Sci 96 143 148
49. M Takahashi J Ritz GM Cooper 1985 Activation of a novel human transforming gene, ret, by DNA rearrangement Cell 42 581 588
50. C Eng 1999 RET proto-oncogene in the development of human cancer J Clin Oncol 17 380 393